Endolysins are phage-encoded lytic enzymes that degrade bacterial peptidoglycan at the end of phage lytic cycles to release new phage particles. These enzymes are being explored as an alternative to small-molecule antibiotics.
Methods:
The crystal structure of KTN6 Gp46 was determined and compared with a ColabFold model. Cleavage specificity was examined using a peptidoglycan digest and reversed-phase high-performance liquid chromatography coupled to mass spectrometry (HPLC/MS).
Results:
The structure of KTN6 Gp46 could be determined at 1.4 Å resolution, and key differences in loops of the putative peptidoglycan binding domain were identified in comparison with its closest known homologue, the endolysin of phage SPN1S. Reversed-phase HPLC/MS analysis of the reaction products following peptidoglycan digestion confirmed the muramidase activity of Gp46, consistent with structural predictions.
Conclusion:
These insights into the structure and function of endolysins further expand the toolbox for endolysin engineering and explore their potential in enzyme-based antibacterial design strategies.
CzaplewskiL, BaxR, ClokieM, et al.Alternatives to antibiotics-a pipeline portfolio review. Lancet Infect Dis, 2016; 16(2):239–251; doi: 10.1016/S1473-3099(15)00466-1
5.
GrishinAV, KaryaginaAS, VasinaDV, et al.Resistance to peptidoglycan-degrading enzymes. Crit Rev Microbiol, 2020; 46(6):703–726; doi: 10.1080/1040841X.2020.1825333
6.
ButlerMS, PatersonDL. Antibiotics in the clinical pipeline in October 2019. J Antibiot (Tokyo), 2020; 73(6):329–364; doi: 10.1038/s41429-020-0291-8
7.
MartensE, DemainAL. The antibiotic resistance crisis, with a focus on the United States. J Antibiot (Tokyo), 2017; 70(5):520–526; doi: 10.1038/ja.2017.30
8.
Levin-ReismanI, RoninI, GefenO, et al.Antibiotic tolerance facilitates the evolution of resistance. Science, 2017; 355(6327):826–830; doi: 10.1126/science.aaj2191
9.
TheuretzbacherU, GottwaltS, BeyerP, et al.Analysis of the clinical antibacterial and antituberculosis pipeline. Lancet Infect Dis, 2019; 19(2):e40–e50; doi: 10.1016/S1473-3099(18)30513-9
10.
De MaesschalckV, GutiérrezD, PaeshuyseJ, et al.Advanced engineering of third-generation lysins and formulation strategies for clinical applications. Crit Rev Microbiol, 2020; 46(5):548–564; doi: 10.1080/1040841X.2020.1809346
11.
BriersY, WalmaghM, Van PuyenbroeckV, et al.Engineered endolysin-based “Artilysins” to combat multidrug-resistant gram-negative pathogens. mBio, 2014; 5(4):e01379-14–e01314; doi: 10.1128/mBio.01379-14
12.
VerbreeCT, DätwylerSM, MeileS, et al.Identification of peptidoglycan hydrolase constructs with synergistic staphylolytic activity in cow’s milk. Appl Environ Microbiol, 2017; 84(1):e02134-17; doi: 10.1128/AEM.02134-17
13.
YangH, ZhangH, WangJ, et al.A novel chimeric lysin with robust antibacterial activity against planktonic and biofilm methicillin-resistant Staphylococcus aureus. Sci Rep, 2017; 7:40182; doi: 10.1038/srep40182
14.
Danis-WlodarczykK, OlszakT, ArabskiM, et al.Characterization of the newly isolated lytic bacteriophages KTN6 and KT28 and their efficacy against Pseudomonas aeruginosa biofilm. PLoS One, 2015 May 21;10(5):e0127603; doi: 10.1371/journal.pone.0127603 Erratum in: PLoS One. 2015;10(8):e0137015.
15.
CamachoC, CoulourisG, AvagyanV, et al.BLAST+: Architecture and applications. BMC Bioinformatics, 2009; 10:421; doi: 10.1186/1471-2105-10-421
16.
ZimmermannL, StephensA, NamSZ, et al.A completely reimplemented MPI bioinformatics toolkit with a new HHpred server at its core. J Mol Biol, 2018; 430(15):2237–2243; doi: 10.1016/j.jmb.2017.12.007
17.
PotterSC, LucianiA, EddySR, et al.HMMER web server: 2018 update. Nucleic Acids Res, 2018; 46(W1):W200–W204; doi: 10.1093/nar/gky448
18.
MistryJ, ChuguranskyS, WilliamsL, et al.Pfam: The protein families database in 2021. Nucleic Acids Res, 2021; 49(D1):D412–D419; doi: 10.1093/nar/gkaa913
19.
QuevillonE, SilventoinenV, PillaiS, et al.InterProScan: Protein domains identifier. Nucleic Acids Res, 2005; 33(Web Server issue):W116–20; doi: 10.1093/nar/gki442
20.
KelleyLA, MezulisS, YatesCM, et al.The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc, 2015; 10(6):845–858; doi: 10.1038/nprot.2015.053
21.
MirditaM, SchützeK, MoriwakiY, et al.ColabFold: Making protein folding accessible to all. Nat Methods, 2022; 19(6):679–682; doi: 10.1038/s41592-022-01488-1
22.
JuanhuixJ, Gil-OrtizF, CuníG, et al.Developments in optics and performance at BL13-XALOC, the macromolecular crystallography beamline at the ALBA synchrotron. J Synchrotron Radiat, 2014; 21(Pt 4):679–689; doi: 10.1107/S160057751400825X
EvansPR, MurshudovGN. How good are my data and what is the resolution? Acta Crystallogr D Biol Crystallogr, 2013; 69(Pt 7):1204–1214; doi: 10.1107/S0907444913000061
25.
AgirreJ, AtanasovaM, BagdonasH, et al.The CCP4 suite: Integrative software for macromolecular crystallography. Acta Crystallogr D Struct Biol, 2023; 79(Pt 6):449–461; doi: 10.1107/S2059798323003595
26.
VaginA, TeplyakovA. Molecular replacement with MOLREP. Acta Crystallogr D Biol Crystallogr, 2010; 66(Pt 1):22–25; doi: 10.1107/S0907444909042589
27.
MurshudovGN, SkubákP, LebedevAA, et al.REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr D Biol Crystallogr, 2011; 67(Pt 4):355–367; doi: 10.1107/S0907444911001314
28.
LangerG, CohenSX, LamzinVS, et al.Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7. Nat Protoc, 2008; 3(7):1171–1179; doi: 10.1038/nprot.2008.91
29.
CasañalA, LohkampB, EmsleyP. Current developments in Coot for macromolecular model building of Electron Cryo-microscopy and Crystallographic Data. Protein Sci, 2020; 29(4):1069–1078; doi: 10.1002/pro.3791
30.
WilliamsCJ, HeaddJJ, MoriartyNW, et al.MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci, 2018; 27(1):293–315; doi: 10.1002/pro.3330
31.
BondCS. TopDraw: A sketchpad for protein structure topology cartoons. Bioinformatics, 2003; 19(2):311–312; doi: 10.1093/bioinformatics/19.2.311
32.
HolmL. Dali server: Structural unification of protein families. Nucleic Acids Res, 2022; 50(W1):W210–W215; doi: 10.1093/nar/gkac387
33.
SieversF, HigginsDG. Clustal Omega for making accurate alignments of many protein sequences. Protein Sci, 2018; 27(1):135–145; doi: 10.1002/pro.3290
34.
RobertX, GouetP. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res, 2014; 42(Web Server issue):W320–W324; doi: 10.1093/nar/gku316
35.
GlaunerB. Separation and quantification of muropeptides with high-performance liquid chromatography. Anal Biochem, 1988; 172(2):451–464; doi: 10.1016/0003-2697(88)90468-x
36.
ParkY, LimJA, KongM, et al.Structure of bacteriophage SPN1S endolysin reveals an unusual two-module fold for the peptidoglycan lytic and binding activity. Mol Microbiol, 2014; 92(2):316–325; doi: 10.1111/mmi.12555
37.
HoellIA, DalhusB, HeggsetEB, et al.Crystal structure and enzymatic properties of a bacterial family 19 chitinase reveal differences from plant enzymes. Febs J, 2006; 273(21):4889–4900; doi: 10.1111/j.1742-4658.2006.05487.x
38.
Sanz-GaiteroM, KearyR, Garcia-DovalC, et al.Crystal structure of the lytic CHAP(K) domain of the endolysin LysK from Staphylococcus aureus bacteriophage K. Virol J, 2014; 11:133; doi: 10.1186/1743-422X-11-133
39.
VázquezR, Seoane-BlancoM, Rivero-BucetaV, et al.Monomodular Pseudomonas aeruginosa phage JG004 lysozyme (Pae87) contains a bacterial surface-active antimicrobial peptide-like region and a possible substrate-binding subdomain. Acta Crystallogr D Struct Biol, 2022; 78(Pt 4):435–454; doi: 10.1107/S2059798322000936
40.
Rodríguez-RubioL, GerstmansH, ThorpeS, et al.DUF3380 domain from a Salmonella phage endolysin shows potent N-acetylmuramidase activity. Appl Environ Microbiol, 2016; 82(16):4975–4981; doi: 10.1128/AEM.00446-16
41.
Centers for Disease Control and Prevention. Covid-19 U.S. impact on antimicrobial resistance. US Dep Heal Hum Serv CDC: Atlanta, GA; 2022; pp. 1–44.
42.
Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. Centers for Disease Control and Prevention; 2019.
TheuretzbacherU, OuttersonK, EngelA, et al.The global preclinical antibacterial pipeline. Nat Rev Microbiol, 2020; 18(5):275–285; doi: 10.1038/s41579-019-0288-0
45.
CassinoC, MurphyG, BoyleJ, et al.Results of the first in human study of lysin CF-301 evaluating the safety, tolerability and pharmacokinetic profile in healthy volunteers, poster EVLB62. 26th Eur Congr Clin Microbiol Infect Dis, Amsterdam, Netherlands; 2016.
46.
DuyvejonckL, GerstmansH, StockM, et al.Rapid and high-throughput evaluation of diverse configurations of engineered lysins using the VersaTile technique. Antibiotics, 2021; 10(3):293; doi: 10.3390/antibiotics10030293
47.
KarplusPA, DiederichsK. Assessing and maximizing data quality in macromolecular crystallography. Curr Opin Struct Biol, 2015; 34:60–68; doi: 10.1016/j.sbi.2015.07.003
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
